Apellis Pharmaceuticals
APLS
APLS
79 hedge funds and large institutions have $528M invested in Apellis Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $639M → $528M (-$111M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
79
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$7.67M | |
| 2 | +$5.47M | |
| 3 | +$5.1M | |
| 4 |
Millennium Management
New York
|
+$3.95M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.88M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$3.7M | |
| 3 | -$2.59M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$1.88M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.22M |